By Dr Anthony Luke Byrne

Journal articles

Byrne AL; Bennett MH; Pace NL; Thomas P, 2013, 'Peripheral venous blood gas analysis versus arterial blood gas analysis for the diagnosis of respiratory failure and metabolic disturbance in adults', Cochrane Database of Systematic Reviews, 2013, http://dx.doi.org/10.1002/14651858.CD010841

Huang S; Byrne A; Dimitri A; Thomas PS, 2013, 'RESPIRATORY PRESENTATIONS OF STRONGYLOIDIASIS IN A LOW PREVALENCE SETTING', RESPIROLOGY, 18, pp. 82 - 82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315589700309&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Parker GB; Brotchie H, 2009, 'Reply', ACTA Psychiatrica Scandinavica, 20, pp. 503 - 503

Conference Papers

Byrne A; Lees N; Asgary E; Stumbles E, 2023, 'Prevalence of abnormal oscillometry among ambulatory Long COVID patients', in EUROPEAN RESPIRATORY JOURNAL, EUROPEAN RESPIRATORY SOC JOURNALS LTD, IA, Milan, presented at Annual Congress of the European-Respiratory-Society (ERS), IA, Milan, 09 September 2023 - 13 September 2023, http://dx.doi.org/10.1183/13993003.congress-2023.OA4319

Cysique LA; Allen-Davidian Y; Darley DR; Byrne A; Wilhelm K; Dore G; Matthews G; Brew BJ, 2021, '032 Cognitive deficits are associated with anosmia but not anxio-depressive symptoms in COVID-19', in BMJ Neurology Open, BMJ, pp. a12 - a12, presented at Oral abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.32

Lilburn P; Beiglari L; Fox G; Byrne A, 2019, 'THE TREATMENT CASCADE; THE USE OF PREVENTATIVE PHARMACOTHERAPY FOR LATENT TUBERCULOSIS INFECTION FOLLOWING HIGH RISK NOSOCOMIAL EXPOSURE TO MULTI-DRUG RESISTANT TUBERCULOSIS', in RESPIROLOGY, WILEY, pp. 27 - 27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000531157100056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Byrne A; Bennett M; Symons R; Chaterji R; Pace N; Thomas P, 2018, 'Peripheral venous blood gas analysis versus arterial blood gas analysis for the diagnosis of respiratory failure and metabolic disturbance in adults.', in EUROPEAN RESPIRATORY JOURNAL, EUROPEAN RESPIRATORY SOC JOURNALS LTD, FRANCE, Paris, presented at 28th International Congress of the European-Respiratory-Society (ERS), FRANCE, Paris, 15 September 2018 - 19 September 2018, http://dx.doi.org/10.1183/13993003.congress-2018.PA2301

Byrne AL; Goldberg H; Mckenzie D, 2012, 'BRONCHOSCOPY WITH BRONCHIAL LAVAGE VERSUS SPUTUM FOR THE DIAGNOSIS OF SMEAR NEGATIVE MYCOBACTERIUM TUBERCULOSIS', in RESPIROLOGY, WILEY-BLACKWELL, pp. 83 - 83, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000301120800316&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Preprints

Chang VL; Li Q; Barnes D; Byrne AL; Cho J-G; Foo SW; Goldberg H; Gray T; Harrington Z; Rofail LM; Ulbricht E; Fox GJ, 2025, Three months of weekly rifapentine and isoniazid versus four months of rifampicin for tuberculosis infection: a randomised controlled trial, http://dx.doi.org/10.1101/2025.08.18.25330309

Tanzer JR; Lecca L; Sinche BR; Guzman VS; Wyda JJ; Byrne AL; Chiang SS, 2025, Evaluation of New and Repurposed Tools to Assess Post-Tuberculosis Lung Disease in Adolescents: A Cross-Sectional Analysis., http://dx.doi.org/10.1101/2025.06.29.25330520

McDonald E; Pittet LF; Bonten M; Byrne A; Campbell J; Croda J; Dalcolmo MP; Davidson A; dos Santos G; Gardiner K; Gwee A; Jardim BA; Lacerda MVG; Lucas M; Lynn DJ; Manning L; Marshall HS; Perrett KP; Prat-Aymerich C; Puga MAM; Richmond PC; Rodríguez-Baño J; Wadia U; Warris A; Wood NJ; Curtis N; Messina NL, 2025, Optimising COVID-19 Episode Identification Using Serology and PCR/Rapid Antigen Testing: Insights from the BRACE Trial, http://dx.doi.org/10.1101/2025.03.12.25323795

Almeida C; Durand R; LaHood A; Byrne A; Mendoza-Ticona A; Ygnacio E; Durand F; Lecca L; Pita R; Guerra D; Wong M; Tintaya K; Mitnick C, 2024, “I have to breathe”: A mixed-methods pilot study to assess the feasibility, acceptability, cost, and effectiveness of an intervention for post-tuberculosis lung disease, http://dx.doi.org/10.21203/rs.3.rs-3813549/v1

Dupnik K; Rivera VR; Dorvil N; Akbarnejad H; Gao Y; Liu J; Apollon A; Dumond E; Riviere C; Severe P; Lavoile K; Duran Mendicuti MA; Pierre S; Rouzier V; Walsh KF; Byrne AL; Joseph P; Cremieux P-Y; Pape JW; Koenig SP, 2023, Potential Utility of C-reactive Protein for Tuberculosis Risk Stratification among Patients with Non-Meningitic Symptoms at HIV Diagnosis in Low- and Middle-Income Countries., http://dx.doi.org/10.1101/2023.12.19.23300232

Phetsouphanh C; Jacka B; Ballouz S; Jackson KJL; Wilson D; Manandhar B; Klemm V; Tan H-X; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville S; Kent S; Byrne A; Brew B; Darley D; Dore G; Kelleher A; Matthews G, 2023, Improvement of immune dysregulation and health-related quality of life in individuals with long COVID at 24-months following SARS-CoV-2 infection, http://dx.doi.org/10.1101/2023.08.27.23294704

Cysique L; Jakabek D; Bracken S; Allen-Davidian Y; Heng B; Chow S; Dehhaghi M; Pires AS; Darley D; Byrne A; Phetsouphanh C; Kelleher A; Dore G; Matthews G; Guillemin G; Brew B, 2022, Post-acute COVID-19 cognitive impairment and decline uniquely associate with kynurenine pathway activation: a longitudinal observational study, http://dx.doi.org/10.1101/2022.06.07.22276020

Darley DR; Dore GJ; Byrne A; Plit M; Brew BJ; Kelleher A; Matthews GV, 2021, Limited recovery from post-acute sequelae of SARS-CoV-2 (PASC) at eight months in a prospective cohort, http://dx.doi.org/10.1101/2021.03.29.21254211

Menzies N; Quaife M; Allwood BW; Byrne AL; Coussens AK; Harries AD; Marx FM; Meghji J; Pedrazzoli D; Salomon JA; Sweeney S; van Kampen SC; Wallis RS; Houben RMGJ; Cohen T, The Lifetime Burden of Disease Due to Incident Tuberculosis: A Global Re-Appraisal Including Post-TB Sequelae, http://dx.doi.org/10.2139/ssrn.3944911

Back to profile page